Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays

Proteomics

Volumn 3, Issue 11, 2003, Pages 2085-2090

  Wulfkuhle, Julia D ^a   Aquino, Joy A ^a   Calvert, Valerie S ^b   Fishman, David A ^c   Coukos, George ^d   Liotta, Lance A ^a   Petricoin III, Emanuel F ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Ovarian cancer; Protein microarrays; Signal transduction profiling

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0242608354     PISSN: 16159853     EISSN: None     Source Type: Journal    
DOI: 10.1002/pmic.200300591     Document Type: Article

References (18)

1. Liotta, L. A., Kohn, E. C., Nature 2001, 411, 375-379.
2. Hu, L., Zaloudek, C., Mills, G. B., Gray, J. et al., Clin Cancer Res. 2000, 6, 880-886.
3. Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R. et al., Nat. Genet. 1999, 21, 99-102.
4. Philp, A. J., Campbell, I. G., Leet, C., Vincan, E. et al., Cancer Res. 2001, 61, 7426-7429.
5. Bellacosa, A., De Feo, D., Godwin, A. K., Bell, D.W. et al., Int. J. Cancer 1995, 64, 280-285.
6. Obata, K., Morland, S., Watson, R., Hitchcock, A. et al., Cancer Res. 1998, 58, 2095-2097.
7. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A. et al. Science 1989, 244, 707-712.
8. Lin, W. C., Methods Mol. Biol. 2003, 218, 113-125.
9. Omoto, Y., Hayashi, S., Breast Cancer 2002, 9, 308-311.
10. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M. et al. Nature 2000, 406, 747-752.
11. Ramaswamy, S., Perou, C.M., Lancet 2003, 361, 1576-1577.
12. Richards, J., Le Naour, F., Hanash, S., Beretta, L., Ann. NY Acad. Sci. 2002, 975, 91-100.
13. Paweletz, C. P., Charboneau, L., Bichsel, V.E., Simone, N. L. et al., Oncogene 2001, 20, 1981-1989.
14. Liotta, L. A., Espina,V., Mehta,A. I., Calvert, V. et al., Cancer Cell. 2003, 3, 317-325.
15. Vivanco, I., Sawyers, C. L., Nat. Rev. Cancer 2002, 2, 489-501.
16. Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T. et al., Proc. Natl. Acad. Sci. USA 1992, 89, 9267-9271.
17. Arboleda, J. M., Lyons, J. F., Kabbinavar, F. F., Bray, M. R. et al., Cancer Res. 2003, 63, 196-206.
18. Sun, M., Wang, G., Paciga, J. E., Feldman, R. I. et al., Am. J. Pathol. 2001, 159, 431-437.